February 27, 2019
FunPep, a spinoff of Osaka University, said on February 26 that a PI/IIa study plan of the antibody-inducing peptide FPP003 in patients with psoriasis vulgaris has been approved by a human research ethics committee of an Australian facility that conducts...read more